Nicholas P Giustini
Overview
Explore the profile of Nicholas P Giustini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giustini N, Pritchard C, Kamat N, Menon M
JCO Precis Oncol
. 2024 Jul;
8:e2300215.
PMID: 38991179
Up-front osimertinib leads to clinical benefit in EGFR V834L and L858R comutated NSCLC.
2.
Giustini N, Oh H, Eaton K
JTO Clin Res Rep
. 2022 Nov;
3(11):100419.
PMID: 36340796
TRK inhibition can lead to on-target neurologic adverse events. Two cases illustrate the development of neuropathic arthropathy as a side effect of entrectinib. After starting entrectinib, both patients developed foot...
3.
Giustini N, Patel S, Myall N, Fernando do Prado Moura J, Kulkarni A, Chao R, et al.
JCO Precis Oncol
. 2022 Aug;
6:e2100551.
PMID: 35952324
No abstract available.
4.
Advances in Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Targeted Therapy
Giustini N, Jeong A, Buturla J, Bazhenova L
Clin Chest Med
. 2020 May;
41(2):223-235.
PMID: 32402358
The treatment of metastatic non-small cell lung cancer (NSCLC) is constantly evolving. Although the advent of immunotherapy has played an important role in the treatment of patients with NSCLC, the...
5.
Giustini N, Bazhenova L
Thorac Surg Clin
. 2020 Apr;
30(2):147-156.
PMID: 32327173
ROS1-rearranged non-small cell lung cancer (NSCLC) makes up approximately 1% to 2% of all NSCLC, is oncogenically driven by a constitutively activated ROS1 kinase paired with certain fusion partners, and...
6.
Rose C, Hayes M, Stettler G, Hickey S, Axelrod T, Giustini N, et al.
Analyst
. 2010 Sep;
135(11):2945-51.
PMID: 20820497
The emergence of functional genomics and proteomics has added to the growing need for improved analysis methods that can detect and distinguish between protein variants resulting from allelic variation, mutation,...